Lamotrigine poisoning presenting as seizures: a case of deliberate poisoning

T Willis1, H Roper, L Rabb

  • 1Department of Neurology, Birmingham Children's Hospital, Birmingham, UK.

Child Abuse & Neglect
|January 9, 2007
PubMed

Insights

Lamotrigine poisoning in children is poorly understood. This case report details a child experiencing seizures and unusual neurological symptoms due to lamotrigine overdose.

Area of Science:

  • Pediatric Toxicology
  • Neurology
  • Clinical Case Reports

Background:

  • Lamotrigine is an anticonvulsant medication used to treat epilepsy and bipolar disorder.
  • Information on lamotrigine poisoning in pediatric populations is limited.
  • Accurate diagnosis and management of pediatric poisoning are crucial.

Observation:

  • A child presented with new-onset seizures and peculiar neurological manifestations.
  • The child's symptoms were initially unclear and difficult to attribute to a specific cause.
  • A thorough medical history and diagnostic workup were performed.

Findings:

  • The child's symptoms were definitively linked to lamotrigine poisoning.
  • The case highlights the potential for severe neurological effects in children with lamotrigine overdose.
  • Specific clinical features of lamotrigine poisoning in children were observed.

Implications:

  • This case underscores the need for increased awareness of lamotrigine toxicity in children.
  • Clinicians should consider lamotrigine poisoning in pediatric patients presenting with unexplained seizures and neurological symptoms.
  • Further research is warranted to better define the clinical spectrum and management of lamotrigine poisoning in pediatric patients.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...